These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8545700)

  • 21. Amiodarone-induced pulmonary interstitial fibrosis.
    Iliopoulou A; Pagou H; Giannakopoulos G; Spiropoulos T
    Intensive Care Med; 2000 Oct; 26(10):1585. PubMed ID: 11126282
    [No Abstract]   [Full Text] [Related]  

  • 22. Amiodarone-induced acute lung toxicity in an ICU setting.
    Skroubis G; Galiatsou E; Metafratzi Z; Karahaliou A; Kitsakos A; Nakos G
    Acta Anaesthesiol Scand; 2005 Apr; 49(4):569-71. PubMed ID: 15777308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amiodarone-associated hemoptysis.
    Ravishankar R; Samuels LE; Kaufman MS; Samuels FL; Thomas MP; Galindo L; Morris RJ; Brockman SK
    Am J Med Sci; 1998 Dec; 316(6):390-2. PubMed ID: 9856693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amiodarone-induced adult respiratory distress syndrome after nonthoracotomy subcutaneous defibrillator implantation.
    Liverani E; Armuzzi A; Mormile F; Anti M; Gasbarrini G; Gentiloni N
    J Intern Med; 2001 Jun; 249(6):565-6. PubMed ID: 11422664
    [No Abstract]   [Full Text] [Related]  

  • 25. Amiodarone toxicity presenting as pulmonary mass and peripheral neuropathy: the continuing diagnostic challenge.
    Azzam I; Tov N; Elias N; Naschitz JE
    Postgrad Med J; 2006 Jan; 82(963):73-5. PubMed ID: 16397086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone-induced alveolar haemorrhage: a rare complication of a common medication.
    Tanawuttiwat T; Harindhanavudhi T; Hanif S; Sahloul MZ
    Heart Lung Circ; 2010 Jul; 19(7):435-7. PubMed ID: 20356785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of amiodarone-induced hyperthyroidism by carbimazole with maintenance of amiodarone].
    Talard P; Bonal J; Cellarier G; Bouchiat C; Dussarat GV
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1301-3. PubMed ID: 8952829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of amiodarone-associated pulmonary toxicity.
    Kwon KH; Jeong SW; Uh S; Kim YH; Jin SY; Park JS; Kang CH; Park CS
    Korean J Intern Med; 1995 Jul; 10(2):155-9. PubMed ID: 7495776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
    Sapp JL; Wells GA; Parkash R; Stevenson WG; Blier L; Sarrazin JF; Thibault B; Rivard L; Gula L; Leong-Sit P; Essebag V; Nery PB; Tung SK; Raymond JM; Sterns LD; Veenhuyzen GD; Healey JS; Redfearn D; Roux JF; Tang AS
    N Engl J Med; 2016 Jul; 375(2):111-21. PubMed ID: 27149033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicity.
    Devine PL; Siebert WJ; Morton SL; Scells B; Quin RJ; Heddle WF; Zimmerman PV; Donohoe PJ
    Dis Markers; 1998 Nov; 14(3):169-75. PubMed ID: 10427477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy-resistant ventricular tachycardia caused by amiodarone-induced thyrotoxicosis: a case report of electrical storm.
    Erdogan HI; Gul EE; Gok H; Nikus KC
    Am J Emerg Med; 2012 Nov; 30(9):2092.e5-7. PubMed ID: 22386340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonsustained polymorphous ventricular tachycardia during amiodarone therapy for atrial fibrillation complicating cardiomyopathy. Management with intravenous magnesium sulfate.
    Winters SL; Sachs RG; Curwin JH
    Chest; 1997 May; 111(5):1454-7. PubMed ID: 9149614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiodarone-induced acute respiratory distress syndrome masquerading as acute heart failure.
    Kumar S; Bangalore S; Kumari R; Grosu H; Jean R
    J Emerg Med; 2012 Nov; 43(5):e311-4. PubMed ID: 21459542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amiodarone-induced pulmonary toxicity].
    Heisel A; Berg M; Stopp M; Ukena D; Schieffer H
    Med Klin (Munich); 1997 Dec; 92 Suppl 5():33-6. PubMed ID: 19479394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and therapeutic aspects of amiodarone induced thyroid dysfunction.
    Costache II; Aprotosoaie AC
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):375-9. PubMed ID: 24340519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations.
    Pollak PT
    Am J Cardiol; 1999 Nov; 84(9A):37R-45R. PubMed ID: 10568658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can amiodarone pulmonary toxicity be predicted in patients undergoing implantable cardioverter defibrillator implantation?
    Hawthorne HR; Wood MA; Stambler BS; Damiano RJ; Ellenbogen KA
    Pacing Clin Electrophysiol; 1993 Dec; 16(12):2241-9. PubMed ID: 7508601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syndrome of inappropriate antidiuretic hormone secretion induced by amiodarone therapy.
    Aslam MK; Gnaim C; Kutnick J; Kowal RC; McGuire DK
    Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):831-2. PubMed ID: 15189547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Examining the effect of amiodarone on the lung: data of prospective study].
    Reĭngardene DI; Azarvichene AP; Korobkova IZ
    Vestn Rentgenol Radiol; 2003; (6):29-31. PubMed ID: 14674352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute Hepatotoxicity of Intravenous Amiodarone: Case Report and Review of the Literature.
    Chen CC; Wu CC
    Am J Ther; 2016; 23(1):e260-3. PubMed ID: 25259952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.